BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2020 9:52:05 AM | Browse: 744 | Download: 2419
 |
Received |
|
2020-03-04 12:06 |
|
Peer-Review Started |
|
2020-03-04 12:06 |
|
First Decision by Editorial Office Director |
|
2020-04-14 18:09 |
|
Return for Revision |
|
2020-04-14 18:09 |
|
Revised |
|
2020-06-02 08:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-06-22 09:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-06-23 01:26 |
|
Articles in Press |
|
2020-06-23 01:26 |
|
Edit the Manuscript by Language Editor |
|
2020-07-14 08:29 |
|
Typeset the Manuscript |
|
2020-08-04 06:09 |
|
Publish the Manuscript Online |
|
2020-08-06 09:52 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Observational Study |
| Article Title |
Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lu Wang, Hai-Yun Guan, He-Xia Xia, Xiu-Ying Chen and Wei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Abbott (32F Crio's Plaza, 388 West Nanjing Road, Shanghai, China) |
A14-390 |
|
| Corresponding Author |
Wei Zhang, MD, Professor, Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital of Fudan University, No. 419 Fangxie Road, Shanghai 200011, China. zhangwei623@hotmail.com |
| Key Words |
Dydrogesterone; Abnormal uterine bleeding-ovulation dysfunction; Menstrual cycle; Hormone; Testosterone; Dehydroepiandrosterone sulfate |
| Core Tip |
The normal interval of menstrual-cycle is typically 21 to 35 d and duration of normal menstrual flow is generally 5 d. Abnormal uterine bleeding continues to pose significant physical and financial burdens on patients. In the study, we analyzed the data that 114 women with abnormal uterine bleeding - ovulation dysfunction had been prescribed dydrogesterone and treated with dydrogesterone 10 mg from day 16 to day 25 of each cycle, being consecutive at least 3 cycles. Based on these data, suggested that dydrogesterone therapy was effective in achieving menstrual-cycle regularization for Chinese patients with abnormal uterine bleeding-ovulation dysfunction. |
| Publish Date |
2020-08-06 09:52 |
| Citation |
Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients. World J Clin Cases 2020; 8(15): 3259-3266 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i15/3259.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i15.3259 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
